Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[2.]
C.H.R. Vitek, B.F.B. Pascual, A.C. Baughman, T.V. Murphy.
Increase in deaths from pertussis among young infants in the United States in the 1990.
Pediatric Infect Dis J, 22 (2003), pp. 628-634
[3.]
Grupo de Trabajo sobre Tos ferina.Tos ferina en Espana, aproximacion a la incidencia de la enfermedad y a los efectos de la vacunacion en adolescentes y adultos. Madrid: Area de vigilancia de la salud publica. Programa Nacional de vacunaciones. Centro Nacional de Epidemiologia. Instituto de Salud Carlos III. Disponible en:http://www.cne.isciii.es
[4.]
Centers for Disease and Prevention.
Pertussis-United States, 1997-2000.
Mmwr, 51 (2002), pp. 73-76
[5.]
M. Campins-Marti, H.K. Cheng, K. Forsyth, N. Guiso, S. Halperin, L.M. Huang, et al.
Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration.
Vaccine, 20 (2001), pp. 641-646
[6.]
E.L. Hewlett.
Pertussis: current concepts of pathogenesis and prevention.
Pediatr Infect Dis J, 16 (1997), pp. 578-584
[8.]
J. Van Savage, M.D. Decker, K.M. Edwars, S.H. Sell, D.T. Karzon.
Natural history of pertussis antibody in the infant and effect on vaccine response.
J Infect Dis, 161 (1990), pp. 487-492
[9.]
T. Madsen.
Vaccination against whooping cough.
Jama, 101 (1933), pp. 187-188
[10.]
E. Miller, L.A. Ashworth, K. Redhead, C. Thornton, P.A. Waight, T. Coleman.
Effects of schedule on reactogenicity and antibody persistence of acellular and whole- cell pertussis vaccines: value of laboratory tests as predictors of clinical performance.
Vaccine, 15 (1997), pp. 51-60
[11.]
F. Simondon, M.P. Preziosi, A. Yam, C.T. Kane, L. Chabirand, I. Iteman, et al.
A randomized double-blind trial comparing a two-component acellular to a wholecell pertussis vaccine in Senegal Vaccine, 15 (1997), pp. 1606-1612
[12.]
K. Kanai.
Japan's experience in pertussis epidemiology and vaccination in the past thirty years.
Jpn J Med Sci Biol, 33 (1980), pp. 107-143
[13.]
J.D. Cherry.
The epidemiology of pertussis and pertussis vaccine in the United Kingdom and the United States: a comparative study.
Curr Probl Pediatr, 14 (1984), pp. 1-78
[14.]
V. Romanus, R. Jonsell, S.O. Bergquist.
Pertussis in Sweden after cessation of general inmunitation in 1979.
Pediatr Infect Dis J, 6 (1987), pp. 364-671
[15.]
K.M. Edwards, M.D. Decker, J.r. Mortimer EA.
Pertussis Vaccine.
Vaccines, 3rd e.d, pp. 293-344
[16.]
Comite Asesor de Vacunas.
Asociacion Espanola de Pediatria. Calendario vacunal de la Asociacion Espanola de Pediatria 2003.
An Pediatr (Barc), 58 (2003), pp. 257-262
[17.]
J.D. Cherry, J. Gombein, U. Heininger, K. Stehr.
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses vaccine, 20 (1998), pp. 1901-1906
[18.]
J. Storgaeter, H.O. Hallander, L. Gustafsson, P. Olin.
Levels of anti-pertussis antibodys related to protection after household exposure to Bordetella pertussis.
Vaccine, 20 (1998), pp. 1907-1916
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados